-
Monday, April 1, 2024
Charles (Chuck) Murry, MD, PhD, has been appointed as the next chair of the Department of Stem Cell Biology and Regenerative Medicine and the director of the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at the Keck School of Medicine of USC. Effective Aug. 1, he... Read More »
-
Thursday, March 28, 2024
Researchers from USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, are preparing a first-of-its-kind clinical trial to determine whether non-small cell lung cancer can be treated at home with subcutaneous immunotherapy. Currently, patients who need immunotherapy must receive the treatment in a clinic or hospital. If at-home... Read More »
-
Wednesday, March 27, 2024
In a special State of the University address written and delivered to the Health Sciences Campus community, USC President Carol L. Folt spoke on the prestige of its programs, commended the nationally renowned achievements of its researchers and shared updates on moonshot initiatives. To read the full story, click here.... Read More »
-
Wednesday, March 27, 2024
Krist Azizian, PharmD, MHA, chief pharmacy officer for Keck Medicine of USC, and Andy Gelejian, PharmD, director of 340B and Pharmacy Enterprise Operations for Keck Medicine, visited Capitol Hill on March 20-21 to advocate for the 340B Drug Pricing Program. 340B refers to the section of the Public Health Service... Read More »
-
Tuesday, March 26, 2024
The USC Division of Biokinesiology and Physical Therapy has named Alan Jette, PT, PhD, MPH, the keynote speaker for its commencement ceremony in May. Jette is internationally recognized for his award-winning contributions to the field of physical therapy, such as groundbreaking advancements in disability rehabilitation. To learn more about Jette,... Read More »
-
Tuesday, March 26, 2024
On March 25, Sandra Chen Lau joined Keck Medicine of USC as the new president of the USC Arcadia Hospital Foundation. She succeeds Mike Driebe, who is retiring after a 14-year tenure in the position. An announcement from Ikenna “Ike” Mmeje, MHSA, president of USC Arcadia Hospital, stated, “Lau will... Read More »
-
Wednesday, March 20, 2024
Funded by $2.7 million from the California Institute for Regenerative Medicine, Linda Sher, MD, is collaborating with Renovate Biosciences to develop a new source of organs for transplantation — immunologically modified human livers grown in pigs. Sher, who is chief of clinical research in the Keck School of Medicine of... Read More »
-
Wednesday, March 20, 2024
The American Occupational Physical Therapy Association (AOTA) has announced that Katie Jordan, OTD, OTR/L, a key leader at the USC Chan Division of Occupational Science and Occupational Therapy, will become the association's executive director on Aug. 7. In her new role, Jordan will provide strategic leadership of AOTA, in partnership... Read More »
-
Wednesday, March 20, 2024
On Match Day 2024, Keck School of Medicine of USC's graduating medical students discovered where their careers would take them next. Friends and family members looked on as the students opened personalized envelops at exactly 9 a.m., PDT — in synchronicity with other students across the nation — and learned... Read More »
-
Thursday, March 14, 2024
A clinical trial from Keck Medicine of USC aims to provide a surgical solution for patients with a form of advanced pancreatic cancer previously considered inoperable. Until now, pancreatic cancer treatment has been limited to chemotherapy and radiation because the pancreas is surrounded and filled with arteries that carry blood to the rest of... Read More »
-
Wednesday, March 13, 2024
According to a multidisciplinary study from USC, Medicare Part D plans have significantly increased restrictions on prescription drugs, excluding more compounds from coverage or subjecting more of them to review before patients could access the treatments. The results, published in Health Affairs, showed that the share of drug compounds that was... Read More »